Completed
BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
NCT02047110
- Conditions
- Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +9 more
- Locations
-
Not specified